Marine natural products as antituberculosis agents

Tetrahedron

Volumn 56, Issue 7, 2000, Pages 949-953

  El Sayed, Khalid A ^a   Bartyzel, Piotr ^a   Shen, Xiaoyu ^a   Perry, Tony L ^a   Zjawiony, Jordan K ^a   Hamann, Mark T ^a  

^a UNIVERSITY OF MISSISSIPPI   (United States)

Author keywords

Antibiotics; Biologically active compounds; Marine metabolites; Natural products

Indexed keywords

HYDROXYSTEROID; ISOXAZOLINE DERIVATIVE; KAHALALIDE DERIVATIVE; NATURAL PRODUCT; PEPTIDE DERIVATIVE; PUUPEHENONE DERIVATIVE; QUINONE DERIVATIVE; SESQUITERPENOID; TETRABROMOSPIROCYCLOHEXADIENYLISOXAZOLINE; TUBERCULOSTATIC AGENT; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; DRUG RESEARCH; DRUG STRUCTURE; IN VITRO STUDY; MINIMUM INHIBITORY CONCENTRATION; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL;

EID: 0034635385     PISSN: 00404020     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0040-4020(99)01093-5     Document Type: Article

References (33)

1. Mdluli K., Slayden R.A., Zhu Y., Ramaswamy S., Pan X., Mead D., Crane D.D., Musser J.M., Barry C.E. III. Science. 280:1998;1607.
2. Rouhi A.M. Chem. Eng. News. 17:1999;52.
3. Snell N.J.C. Expert Opin. Invest. Drugs. 7:1998;545.
4. Smith C.M., Reynard A.M. Treatment of Tuberculosis. Essentials of Pharmacology. 1995;395 W.B. Saunders, Philadelphia.
5. Heym B., Cole S.T. Int. J. Antimicrob. Agents. 8:1997;61.
6. Klepser M.E., Klepser T.B. Drugs. 53:1997;40.
7. Centers for Disease Control. A Strategic Plan for the Elimination of Tuberculosis in the United States. Morbidity and Mortality Weekly Report 1989, 38, p 1.
8. Centers for Disease Control. Tuberculosis and Human Immunodeficiency Virus Infection: Recommendations of the Advisory Committee for the Elimination of Tuberculosis (ACET). Morbidity and Mortality Weekly Report 1989, 38, pp 236-238, 243.
9. Duncan K. Expert Opin. Ther. Pat. 8:1998;137.
10. Godlee F. Br. Med. J. 306:1993;1147.
11. Rang H.P., Dale M.M., Ritter J.M., Gardner P. Antimycobacterial Agents. Pharmacology. 3: 1995;738 Churchill Livingstone, New York.
12. DiGiacomo M.A. Newsweek. March 16:1992;53.
13. Davis P.D.O. J. Antimicrob. Chemother. 37:1996;5.
14. Gerard J., Lloyd R., Barsby T., Haden P., Kelly M.T., Andersen R.J. J. Nat. Prod. 60:1997;223.
15. Rodriguez A.D., Ramirez C., Rodriguez I.I., Gonzalez E. Org. Lett. 1:1999;527.
16. Hamann M.T., Scheuer P.J. J. Am. Chem. Soc. 115:1993;5825.
17. Hamann M.T., Otto C.S., Scheuer P.J., Dunbar D.C. J. Org. Chem. 61:1996;6594.
18. Iguchi K., Saitoh S., Yamada Y. Chem. Pharm. Bull. 37:1989;2553.
19. Liu, J.; Zeng, L.; Wu, D. Gaodeng Xuexiao Huaxue Xuebao 1992, 13, 341; Chem. Abstr. 117, 230411y.
20. Liu, J.; Zeng, L.; Wu, D. Gaodeng Xuexiao Huaxue Xuebao 1992, 13, 341; Chem. Abstr. 117, 230411y.
21. Hamann M.T., Scheuer P.J., Kelly-Borges M. J. Org. Chem. 58:1993;6565.
22. Nasu S.S., Yeung B.K.S., Hamann M.T., Scheuer P.J., Kelly-Borges M., Goins K.D. J. Org. Chem. 60:1995;7290.
23. Zjawiony J.K., Bartyzel P., Hamann M.T. J. Nat. Prod. 61:1998;1502.
24. Kazlauskas R., Murphy P.T., Quinn R.J., Wells R.J. Tetrahedron Lett. 17:1976;2631.
25. Moody K., Thomson R.H., Fattorusso E., Minale L., Sodano G. J. Chem. Soc., Perkin Trans. 10:1972;18.
26. Kernan M.R., Cambie R.C., Bergquist P.R. J. Nat. Prod. 53:1990;615.
27. Acosta A.L., Rodriguez A.D. J. Nat. Prod. 55:1992;1007.
28. Gao H., Kelly M., Hamann M.T. Tetrahedron. 55:1999;9717.
29. Osinga R., Tramper J., Wijffels R.H. Trends Biotechnol. 16:1998;130.
30. El Sayed K.A., Dunbar C.D., Goins K.D., Cordova C.R., Perry T.L., Wesson K.J., Sanders S.C., Janus S.A., Hamann M.T. J. Nat. Toxins. 5:1996;261.
31. El Sayed K.A., Dunbar C.D., Perry T.L., Wilkins S.P., Hamann M.T., Greenplate J.T., Wideman M.A. Mar. J. Agric. Food Chem. 45:1997;2735.
32. Siddiqi S.H. Radiometric (BACTEC) Tests for Slowly Growing Mycobacteria. Isenberg H.D. Clinical Microbiology Procedures Handbook. 1:1992;5.14.2-5.14.25 American Society for Microbiology, Washington, DC.
33. Heifets L.B., Lindholm-Levy P.J. Antimicrob. Agents Chemother. 34:1990;770.